Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-κB Pathways in Alzheimer’s Disease: An In Vitro and In Vivo Investigation-Reference-Cited by-同舟云学术

Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-κB Pathways in Alzheimer’s Disease: An In Vitro and In Vivo Investigation

Published:2022-02 Issue: Volume:484 Page:140-150
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Li Yuanlong,Fan Hua,Ni Ming,Zhang Wei,Fang Fengqin,Sun Jun,Lyu Pin,Ma Peizhi

Funder

Beijing Medical and Health Foundation

Publisher

Elsevier BV

Subject

General Neuroscience

Reference45 articles.

1. Deciphering the potential neuroprotective effects of luteolin against abeta1-42-induced Alzheimer's disease;Ahmad;Int J Mol Sci,2021

2. JNK3 as a therapeutic target for neurodegenerative diseases;Antoniou;J Alzheimers Dis,2011

3. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease;Boissiere;Neuroreport,1997

4. Etanercept (SB4): A review in autoimmune inflammatory diseases;Burness;BioDrugs,2016

5. Treatment for rheumatoid arthritis and risk of Alzheimer's disease: A nested case-control analysis;Chou;CNS Drugs,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etanercept ameliorates chronic mild stress-induced depressive-like behavior in rats: Crosstalk between MAPK and STAT3 pathways and norepinephrine and serotonin transporters;European Journal of Pharmacology;2024-09

2. Perispinal etanercept stroke trial design: PESTO and beyond;Expert Opinion on Biological Therapy;2024-08-23

3. Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease;Science Translational Medicine;2024-08-21

4. Melatonin improves cognitive dysfunction and decreases gliosis in the streptozotocin-induced rat model of sporadic Alzheimer’s disease;Frontiers in Pharmacology;2024-07-29

5. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05